Treace Medical Concepts, Inc.
TMCI
$4.16
$0.102.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 207.32M | 212.69M | 218.88M | 213.75M | 210.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 207.32M | 212.69M | 218.88M | 213.75M | 210.82M |
| Cost of Revenue | 42.05M | 42.94M | 44.05M | 42.50M | 41.64M |
| Gross Profit | 165.27M | 169.75M | 174.83M | 171.25M | 169.18M |
| SG&A Expenses | 200.66M | 202.62M | 201.31M | 197.92M | 200.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 262.06M | 265.84M | 266.32M | 261.65M | 263.12M |
| Operating Income | -54.74M | -53.15M | -47.44M | -47.89M | -52.30M |
| Income Before Tax | -61.04M | -59.00M | -50.11M | -49.18M | -52.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.04 | -59.00 | -50.11 | -49.18 | -52.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.04M | -59.00M | -50.11M | -49.18M | -52.99M |
| EBIT | -54.74M | -53.15M | -47.44M | -47.89M | -52.30M |
| EBITDA | -46.68M | -43.53M | -38.38M | -39.46M | -44.33M |
| EPS Basic | -0.96 | -0.93 | -0.79 | -0.79 | -0.85 |
| Normalized Basic EPS | -0.56 | -0.55 | -0.49 | -0.49 | -0.53 |
| EPS Diluted | -0.96 | -0.93 | -0.80 | -0.79 | -0.85 |
| Normalized Diluted EPS | -0.56 | -0.55 | -0.49 | -0.49 | -0.53 |
| Average Basic Shares Outstanding | 254.98M | 253.04M | 251.52M | 250.24M | 249.31M |
| Average Diluted Shares Outstanding | 254.98M | 253.04M | 251.52M | 250.24M | 249.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |